Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
SMC ‘accepted for use’ and ‘accepted for restricted use’ advice - an investigation of medicines utilisation across Scotland. These medicine profiles provide information on the use of SMC ‘accepted for use’ and ‘accepted for restricted use’ medicines in primary care in Scotland. They have been prepared using data from the Prescribing Information System for Scotland (PRISMS) and the manufacturer’s submission to the SMC. Some of this information may now be out of date and should be interpreted with caution. The numbers of patients treated were estimated using the Gross Ingredient Cost (GIC) from PRISMS and costs from the British National Formulary (BNF) or manufacturer’s estimate. The actual patient base, age and sex of patients treated and the indication of the medicine are unknown. For medicines that are accepted for restricted use, it is not possible to identify whether the data reflects the SMC restriction. All data should therefore be interpreted with caution. Click to read the medicine profiles for SMC ‘accepted for use’ and ‘accepted for restricted use’ medicines in primary care M:\Scottish Medicine Consortium\Web Data Audit\corporate\About us\publications\Evaluation\Accepted Restricted Medicine Profiles.pdf Disclaimer: While every effort has been made to ensure that the information contained within the medicine profiles is accurate, no responsibility or liability can be accepted by those involved in their production for any loss, injury or damage which is suffered as a consequence of any errors, omissions or inaccuracies contained within them. In particular, those prescribing drugs should always check the suitability of the drug and dosage based on the information provided by the manufacturer.